Compare Vanguard Total World Stock Index Fund ETF (VT) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Total World Stock Index Fund ETF vs 22nd Century Group Inc — how do they compare? Vanguard Total World Stock Index Fund ETF trades at $161.68, while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). The key difference: Vanguard Total World Stock Index Fund ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| VT | XXII | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $161.30 | $801.00 |
52-Week Low | $132.19 | $3.72 |
Market Cap | — | $1.52M |
Enterprise Value | — | -$6.71M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VT trades at $161.53, up 0.35% today, with a bullish technical signal from moving averages and strong trend momentum indicated by ADX. The ETF offers global diversification across over 10,000 stocks with a low 0.06% expense ratio, though RSI levels suggest short-term overbought conditions. Recent institutional activity includes mixed positioning changes, such as Barry Investment Advisors reducing holdings by 18.7% in Q2 2026 (SEC filing, August 10, 2026).
Outlook remains positive for long-term investors seeking broad global exposure, supported by VT's cost efficiency and diversification benefits. Risks include trade war uncertainties highlighted in news (The Motley Fool, July 31, 2026) and potential volatility from geopolitical events. Analyst sentiment is generally favorable, with comparisons to peers emphasizing VT's lower fees and comprehensive coverage.
22nd Century Group (XXII) trades at $4.31, down 0.92% on the day, with a neutral technical signal and bearish moving averages. The company shows deep unprofitability with a gross margin of -52.19% and net margin of -65.76%, though revenue was $7.05M in 2025. Recent corporate actions include a 20:1 reverse stock split in June 2026, and news highlights retail expansion for VLN reduced-nicotine cigarettes in California and New York.
The outlook remains speculative with high execution risk amid persistent losses, but analyst sentiment is bullish with 75% buy ratings. Key risks include negative cash flow from operations, regulatory hurdles for tobacco products, and the need for successful commercialization of VLN to achieve profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Vanguard Total World Stock Index Fund ETF
VT is a foundational, low-cost ETF that seeks to track the FTSE Global All Cap Index, providing exposure to nearly 10,000 stocks across developed and emerging markets worldwide, including the United States. It serves as a single-ticker solution for total global equity diversification, capturing approximately 98% of the world's investable market capitalization.
Read more on VT →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
